You are here: Industry Insights > Market News > Create a Special Christmas Card and Share with Your Friends!

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

Hot Products

Propantheline Bromide

carbomer 974P

Coenzyme Q10

Refined Fish Oil

Black Currant Extract

Hydrocortisone

Create a Special Christmas Card and Share with Your Friends!

en-CPhI.CNDecember 20, 2017

Tag: en-CPhI.cn , Christmas Card , Christmas Wishes

Favorites

Dear Partners,

Hello, this is Miki, EN-CPhI.cn customer service officer. Thank you for your use and support for our website.

The holiday season offers us a special opportunity to extend our personal thanks to our friends, and our very best wishes for the future.

And so it is the time for us to wish you Merry Christmas and a Happy New Year, and extend our wishes for good health and good cheer.

Wishing you peace, joy and happiness through Christmas and the coming year.

Click here to create a special card of your own!

Write your Christmas wishes, and a special Christmas card of your own is generated which you can send to your friends and relatives.

(Recommend to open the link via mobile or tablet.)

Previous:Wearable Data Analytics Bring Humans into the IoT

Next:MEGGLE – Experts in excipients: The whole world of lactose

InnoCare Announces the Completion of Patient Enrollment in the Phase II Clinical Trial of ICP-488 for the Treatment of Psoriasis

PharmaSourcesMay 16, 2024

InnoCare announced the completion of patient enrollment for the phase II clinical trial of ICP-488, a TYK2 (tyrosine kinase 2) JH2 allosteric inhibitor, for the treatment of psoriasis.

Sartorius Collaborates with Sanofi to Commercialize End-To-End Platform for Downstream Process Intensification

Biotech NewswireMay 14, 2024

Touchlight Genetics and the National Physical Laboratory (NPL) Awarded Grant to Develop Novel Gene-Length Single-Stranded Genome Editing Template

Biotech NewswireMay 10, 2024

Create a Special Christmas Card and Share with Your Friends! | Pharmasources.com

First Commercial Cell and Gene Therapy Product Manufactured at Minaris Regenerative Medicine in Allendale, NJ.

Biotech NewswireMay 09, 2024

The first commercial manufacturing run of LYFGENIA – a one-time gene therapy for the treatment of sickle cell disease developed by bluebird bio – was performed at its Allendale, NJ site.

Create a Special Christmas Card and Share with Your Friends!

Related News

InnoCare Announces the Completion of Patient Enrollment in the Phase II Clinical Trial of ICP-488 for the Treatment of Psoriasis

Sartorius Collaborates with Sanofi to Commercialize End-To-End Platform for Downstream Process Intensification

Touchlight Genetics and the National Physical Laboratory (NPL) Awarded Grant to Develop Novel Gene-Length Single-Stranded Genome Editing Template

First Commercial Cell and Gene Therapy Product Manufactured at Minaris Regenerative Medicine in Allendale, NJ.

You may like